コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rons express dynorphin, somatostatin, and/or corticotropin releasing hormone.
2 xytocin (OT), arginine-vasopressin (AVP), or corticotropin releasing hormone.
3 axis activity secondary to hypersecretion of corticotropin-releasing hormone.
4 evels, showing no response to stimulation by corticotropin-releasing hormone.
5 rphin in response to the usual secretagogue, corticotropin-releasing hormone.
6 s I were identified as potent antagonists of corticotropin-releasing hormone-1 receptor (CRH1-R, also
8 alamic-pituitary-adrenal (HPA) axis hormones-corticotropin-releasing hormone, adrenocorticotropic hor
10 icosterone receptors, their regulator Fkbp5, corticotropin releasing hormone and its receptor, oxytoc
11 the endogenous stress response, principally corticotropin-releasing hormone and its downstream effec
12 he mRNAs encoding the precursor peptides for corticotropin-releasing hormone and neurotensin/neuromed
13 l work has led to the proposal that in PTSD, corticotropin-releasing hormone and noradrenergic system
16 ernal blood (i.e., C-reactive protein (CRP), corticotropin-releasing hormone, and cytokines) were com
17 vasopressin, thyrotropin-releasing hormone, corticotropin-releasing hormone, and somatostatin, are a
18 at several peptide markers (cholecystokinin, corticotropin-releasing hormone, and tachykinin 1) label
19 omatostatin, arginine vasopressin, oxytocin, corticotropin-releasing hormone, and thyrotropin-releasi
20 e of investigation, include treatment with a corticotropin-releasing hormone antagonist and gene ther
22 These neurons, which synthesize and release corticotropin-releasing hormone, arginine vasopressin, a
23 on, and its glutamatergic neurons expressing corticotropin releasing hormone (Bar(Crh/Vglut2)) are im
24 , cortisol, arginine vasopressin, prolactin, corticotropin-releasing hormone, beta-endorphin, and som
25 found that the rs28365143 variant within the corticotropin-releasing hormone binding protein (CRHBP)
27 somatostatin, thyrotropin-releasing hormone, corticotropin-releasing hormone), central autonomic cont
30 of the vagus, DMV) to examine the effects of corticotropin releasing hormone (CRF) on the central com
32 eloped for the detection of the neuropeptide Corticotropin Releasing Hormone (CRH) based on the immob
33 duces long-lasting reduction of hypothalamic corticotropin releasing hormone (CRH) expression and upr
34 Here, we report that transcription of the corticotropin releasing hormone (CRH) gene is regulated
37 ects of intravenous hydrocortisone and ovine corticotropin releasing hormone (CRH) infusions in patie
39 erone levels and elicits c-fos expression in corticotropin releasing hormone (CRH) neurons of the hyp
40 nt male and female offspring received either corticotropin releasing hormone (CRH) or saline intraven
43 te nucleus of the hypothalamus (ARH) and the corticotropin releasing hormone (CRH) system in the para
45 ry-adrenal (HPA) axis through the release of corticotropin releasing hormone (CRH), leading to produc
50 ethylation of the cortisol-regulating genes, corticotropin releasing hormone (CRH; P=0.05) and glucoc
53 luding those that encode the stress hormones corticotropin-releasing hormone (CRH) and adrenocorticot
56 stress-induced c-fos mRNA and a reduction of corticotropin-releasing hormone (CRH) and glucocorticoid
57 al (HPA) axis, including local expression of corticotropin-releasing hormone (CRH) and its receptors
59 n-33 (IL-33), and stress molecules including corticotropin-releasing hormone (CRH) and neurotensin (N
60 ncluding mucosal release of substance P (SP) corticotropin-releasing hormone (CRH) and neutrophil tra
61 ess-induced PVN c-fos mRNA, and elevated PVN corticotropin-releasing hormone (CRH) and parvocellular
62 y-adrenal (HPA) axis, including hypothalamic corticotropin-releasing hormone (CRH) and pituitary cort
63 r (GR), the mineralocorticoid receptor (MR), corticotropin-releasing hormone (CRH) and pro-opiomelano
64 at stress may impact wake regulation through corticotropin-releasing hormone (CRH) and the orexinergi
65 skin have shown expression of the genes for corticotropin-releasing hormone (CRH) and the related ur
67 paired from abnormal expression of amygdalar corticotropin-releasing hormone (CRH) and/or CRH-binding
68 High densities of nerve cells containing corticotropin-releasing hormone (CRH) are located in the
70 s been postulated that altered expression of corticotropin-releasing hormone (CRH) can at least parti
72 cally link the RA-associated marker with the corticotropin-releasing hormone (CRH) candidate gene, an
73 nstem adrenergic and noradrenergic inputs to corticotropin-releasing hormone (CRH) cells of the hypot
74 larval zebrafish with transgenically labeled corticotropin-releasing hormone (CRH) cells, which repre
75 the hypothesis that basal elevations in CSF corticotropin-releasing hormone (CRH) concentrations exi
78 Intracerebroventricular administration of corticotropin-releasing hormone (CRH) elicits a constell
79 employed viral-genetic approaches to reduce corticotropin-releasing hormone (Crh) expression in the
81 ropeptide Y (NPY) expression and to decrease corticotropin-releasing hormone (CRH) expression were no
83 rocortin and urocortin II are members of the corticotropin-releasing hormone (CRH) family of neuropep
84 tress promotes secretion of the neuropeptide corticotropin-releasing hormone (CRH) from hippocampal i
86 axis initiates the production and release of corticotropin-releasing hormone (CRH) from the paraventr
87 activity for the suppression of hypothalamic corticotropin-releasing hormone (CRH) gene expression an
91 ral alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone (CRH) have been implicat
92 Retrograde tracing from the LC combined with corticotropin-releasing hormone (CRH) immunohistochemist
94 of the expression of the stress neurohormone corticotropin-releasing hormone (CRH) in hypothalamic ne
95 experiments investigated the involvement of corticotropin-releasing hormone (CRH) in the BLA in modu
97 reduced expression of the anorectic peptide corticotropin-releasing hormone (CRH) in the paraventric
98 nstrate that a cluster of neurons expressing corticotropin-releasing hormone (Crh) in the pontine mic
99 interaction between neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH) in the regulation
100 ted cytokine oncostatin M induced basal, and corticotropin-releasing hormone (CRH) induced proopiomel
102 hibitory factor (LIF) to strongly potentiate corticotropin-releasing hormone (CRH) induction of POMC
103 transcription factor B (NF-kappaB), whereas corticotropin-releasing hormone (CRH) inhibited both the
117 n of the paraventricular nucleus (PVN) where corticotropin-releasing hormone (CRH) is synthesized.
121 amic area (LHA) show increased expression of corticotropin-releasing hormone (CRH) mRNA as a conseque
122 animals and had two components: (1) reduced corticotropin-releasing hormone (CRH) mRNA in the neuroe
123 like immunoreactivity (Fos-LI) and levels of corticotropin-releasing hormone (CRH) mRNA in the parave
124 sociated with a cocaine-induced reduction of corticotropin-releasing hormone (CRH) mRNA level in the
125 Vasoactive intestinal peptide (VIP) and corticotropin-releasing hormone (CRH) mRNA levels were u
131 tin, thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH) neurons expressed
132 synaptic metaplasticity in stress-responsive corticotropin-releasing hormone (CRH) neurons in female
133 affects excitatory and inhibitory inputs to corticotropin-releasing hormone (CRH) neurons in the hyp
136 naptic plasticity at glutamate synapses onto corticotropin-releasing hormone (CRH) neurons in the par
137 ormation onto paraventricular neuroendocrine corticotropin-releasing hormone (CRH) neurons is a major
138 plasma and Fos (c-fos protein) activation in corticotropin-releasing hormone (CRH) neurons of the fet
140 opic thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH) neurons to regulat
141 lar nucleus (PVN) of hypothalamus, including corticotropin-releasing hormone (CRH) neurons, by induci
142 tical areas transmit signals to hypothalamic corticotropin-releasing hormone (CRH) neurons, which con
143 augments excitatory synaptic strength in PVN corticotropin-releasing hormone (CRH) neurons, with GLP-
144 st physiological actions of the neuropeptide corticotropin-releasing hormone (CRH) on hippocampal pyr
145 sampling before and after administration of corticotropin-releasing hormone (CRH) on separate days.
146 These experiments examined the effects of corticotropin-releasing hormone (CRH) on single-unit ele
147 bria/fornix blocked the excitatory effect of corticotropin-releasing hormone (CRH) on startle (CRH-en
148 el synergistic actions of corticosterone and corticotropin-releasing hormone (CRH) on synaptic physio
150 ing hormone, oxytocin, arginine vasopressin, corticotropin-releasing hormone (CRH) or thyrotropin-rel
151 ress, adrenal corticosterone and hippocampal corticotropin-releasing hormone (CRH) permeate memory-fo
153 could result from estrogen regulation of the corticotropin-releasing hormone (CRH) promoter via eithe
154 creening of our chemical library using a rat corticotropin-releasing hormone (CRH) receptor assay led
156 xpression levels of mRNA encoding the type 1 corticotropin-releasing hormone (CRH) receptor, which ha
158 g-standing paradigm posits that hypothalamic corticotropin-releasing hormone (CRH) regulates neuroend
162 le attention is that 5-HT regulates upstream corticotropin-releasing hormone (CRH) signaling systems
163 petrosal-to-peripheral ACTH gradients before corticotropin-releasing hormone (CRH) stimulation in six
164 e time-integrated cortisol response to human corticotropin-releasing hormone (CRH) stimulation was lo
166 velty have been attributed to differences in corticotropin-releasing hormone (CRH) system function.
168 In addition, increased activation of the corticotropin-releasing hormone (CRH) system within the
169 working memory (WM) deficits; changes to the corticotropin-releasing hormone (CRH) system; and struct
170 vasopressin (AVP) acts synergistically with corticotropin-releasing hormone (CRH) to stimulate ACTH
171 ble cAMP early repressor (ICER), in limiting corticotropin-releasing hormone (CRH) transcription duri
172 ted the effects of the lipophilic nonpeptide corticotropin-releasing hormone (CRH) type 1 receptor an
174 rtisol concentrations and gene expression of corticotropin-releasing hormone (CRH) were not affected
175 e production and release of the neuropeptide corticotropin-releasing hormone (CRH) within the hippoca
176 tyric acid (GABA)(A) receptor with those for corticotropin-releasing hormone (CRH) within the rat hyp
179 lished by blocking the receptor (CRFR(1)) of corticotropin-releasing hormone (CRH), a hippocampal neu
180 n the underlying mechanisms, but the role of corticotropin-releasing hormone (CRH), a hypothalamic ho
182 on the effects of ACTH on the expression of corticotropin-releasing hormone (CRH), a neuropeptide in
183 c stress wherein transgenic mice overexpress corticotropin-releasing hormone (CRH), a primary mediato
186 ormones increased expression of hypothalamic corticotropin-releasing hormone (CRH), ADP had no substa
187 was used to determine the colocalization of corticotropin-releasing hormone (CRH), enkephalin (ENK),
188 nal function, we exploited mice deficient in corticotropin-releasing hormone (CRH), IL-6, or both.
189 se of neuromodulators, including the peptide corticotropin-releasing hormone (CRH), leading to activa
194 nals were collected and processed to measure corticotropin-releasing hormone (CRH), urocortin (Ucn),
195 activities by stimulating the expression of corticotropin-releasing hormone (CRH), urocortin, proopi
196 multilabeled for vasotocin, mesotocin (MT), corticotropin-releasing hormone (CRH), vasoactive intest
197 ormone 44 (Dh44), a homolog of the mammalian corticotropin-releasing hormone (CRH), were specifically
199 ticoids and the stress-released neuropeptide corticotropin-releasing hormone (CRH), which influence t
200 evious studies have described the effects of corticotropin-releasing hormone (CRH), which is released
202 se is characterized by the activation of the corticotropin-releasing hormone (CRH)-adrenocorticotropi
204 ts physiologic importance, we have exploited corticotropin-releasing hormone (CRH)-deficient mice gen
205 he adult brain, we have virally traced local corticotropin-releasing hormone (CRH)-expressing inhibit
206 noreactive boutons in apposition to both the corticotropin-releasing hormone (CRH)-immunoreactive cel
207 corticomedullary interface is innervated by corticotropin-releasing hormone (CRH)-like beaded fibers
208 inhibit acute inflammation via hypothalamic corticotropin-releasing hormone (CRH)-mediated secretion
216 cipal effectors of the stress system include corticotropin-releasing hormone (CRH); arginine vasopres
221 re, we asked if glucocorticoid deficiency in corticotropin-releasing hormone-deficient mice (CRH-/-)
223 ntrast, mRNA levels of another neuropeptide, corticotropin releasing hormone, do not change under the
224 mic activation of the pituitary changes from corticotropin-releasing hormone-dominant to arginine vas
225 one-mediated input, whole-cell recordings of corticotropin-releasing hormone-expressing (CRH(+)) ACs
227 f inhibition by dynorphin, somatostatin, and corticotropin-releasing hormone-expressing neurons in th
229 oked robust upregulation of cholecystokinin, corticotropin releasing hormone, galanin, neuropeptide Y
231 peptides found in the neuroendocrine system: corticotropin-releasing hormone, growth hormone-releasin
232 pheral sites and in tumors, we asked whether corticotropin-releasing hormone has angiogenic propertie
233 refrontal cortex restrains the amygdala, the corticotropin-releasing hormone/hypothalamic-pituitary-a
236 rovide information regarding the function of corticotropin-releasing hormone in peripheral sites and
243 al raphe-originating serotonergic control of corticotropin-releasing hormone-mediated excitation of t
245 way in rat paraventricular hypothalamic CRH (corticotropin-releasing hormone) neuroendocrine neurons
246 loss-of-function mice, either with global or corticotropin-releasing hormone neuron-specific deletion
248 from the nucleus tractus solitarii (NTS) to corticotropin releasing hormone neurons in the paraventr
250 communicated to paraventricular hypothalamic corticotropin-releasing hormone neurons by way of subcor
252 the pathogenesis of IBD include substance P, corticotropin-releasing hormone, neurotensin, and vasoac
258 YO also increased Fos in the majority of corticotropin releasing hormone-positive neurons in the
259 ly blunted Fos activation in the BNST and in corticotropin-releasing hormone-positive PVNmp neurons a
262 erone levels), and alleviated by antalarmin (corticotropin releasing hormone receptor 1 antagonist).
263 cluding the membrane progestin receptor, the corticotropin releasing hormone receptor, and the 5HT1a
265 gated expression of stress-response receptor corticotropin-releasing hormone receptor (CRHR) in bladd
266 e other ligand-binding site defined--for the corticotropin-releasing hormone receptor 1 (CRF1R)--whic
267 lation of the Crhr1 transcript, encoding the corticotropin-releasing hormone receptor 1 (CRH-R1), was
272 51 [FKBP5], glucocorticoid receptor [NR3C1], corticotropin-releasing hormone receptor 1 [CRHR1]) in i
273 ment interaction in which a haplotype in the corticotropin-releasing hormone receptor 1 gene (CRHR1)
274 elch-like protein 2)), chromosome 17 (CRHR1 (corticotropin-releasing hormone receptor 1) and MAPT (mi
275 7, rs77804065 (p = 1.5 x 10(-12)), at CRHR1 (corticotropin-releasing hormone receptor 1); the protein
276 opeptide urocortin 2 (UCN2) and its receptor corticotropin-releasing hormone receptor 2 (CRHR2) are h
279 5'-untranslated region (UTR) of the mRNA on corticotropin-releasing hormone receptor type 1 (CRHR1)
280 5-2 muM) for 6 hours significantly increases corticotropin-releasing hormone receptor-1 (CRHR-1) mRNA
281 found a significant three-way interaction on corticotropin-releasing hormone receptor-1 (Crhr1) gene
282 ally stimulates endothelial chemotaxis via a corticotropin-releasing hormone receptor-dependent mecha
283 bellar Purkinje cells, and co-localized with corticotropin-releasing hormone receptors in the latter.
286 xpression of genes relevant to emotionality: corticotropin-releasing hormone, serotonin, norepinephri
287 in both the initial and replication samples: corticotropin-releasing hormone signaling, cardiac beta-
288 l enrichment analyses revealed enrichment of corticotropin-releasing hormone signaling, GNRH signalin
289 nsity of GABAergic interneurons positive for corticotropin-releasing hormone, somatostatin, or vasoac
291 sulted in higher (125)I-Tyr-oCRH binding and corticotropin-releasing hormone-stimulated cAMP producti
292 utaneous expression of a proopiomelanocortin/corticotropin-releasing hormone system, we investigated
293 y outcomes, including repeated dexamethasone-corticotropin-releasing hormone tests, and psychiatric r
294 cellular oxytocin neurons, and parvicellular corticotropin-releasing hormone, thyrotropin-releasing h
295 ibitory glucocorticoid regulation, including corticotropin-releasing hormone-, thyrotropin-releasing
296 16,311, a selective nonpeptide antagonist of corticotropin-releasing hormone type 1 (CRH(1)) receptor
297 a indicate that genetic variation within the corticotropin-releasing hormone type 1 receptor gene (CR
298 not GABAergic, and do not express oxytocin, corticotropin-releasing hormone, vasopressin, or prodyno
299 epithelial tumor cells engineered to secrete corticotropin-releasing hormone was associated with sign